OMBLASTYS (131 I-OMBURTAMAB-YCWD)
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79358602
- Registration number
- 7341739
- Mark type
- Design + words
- Filed
- 17 Oct 2022
- Published for opposition
- 16 Jan 2024
- Registered
- 02 Apr 2024
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; all of the aforesaid containing monoclonal antibodies
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of in the field of oncology, chemotherapy, and inflammatory diseases, namely antibodies; industrial analysis and research services in the field of chemistry, namely antibodies
Owner
- Y-mAbs Therapeutics, Inc, DE, US
- Y-mAbs Therapeutics, Inc, DE, US
- Y-mAbs Therapeutics, Inc, DE, US
Prosecution history
- 20 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 09 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 17 Oct 2024 — FINAL DISPOSITION PROCESSED
- 03 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2024 — PUBLISHED FOR OPPOSITION
- 13 Jan 2024 — NOTIFICATION PROCESSED BY IB
- 27 Dec 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Dec 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 27 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Dec 2023 — EXAMINER'S AMENDMENT ENTERED